Answers are grounded in this paper and cite their sources.
Background Ultrasound-guided (US-guided) tissue sampling is an increasingly preferred minimally invasive approach for evaluating pediatric pathologies. However, the diagnostic yield and safety of US-guided tissue sampling in pediatric patients in Ethiopia remain poorly characterized. Methods We conducted a retrospective cross-sectional study of pediatric patients who underwent US-guided tissue sampling from July 2022 to June 2024 at Tikur Anbessa Specialized Hospital (TASH), Addis Ababa, Ethiopia. Data on demographics, procedure type, diagnostic yield, and complications were collected. Results A total of 102 US-guided tissue sampling procedures were performed; Core Needle Biopsy (CNB) accounted for 69.6%. The overall diagnostic yield was 93.1%. There was a statistically significant association between procedure type and diagnostic yield, with CNB demonstrating a higher diagnostic yield than Fine Needle Aspiration Cytology (FNAC) (98.6% vs. 80.6%; OR = 16.8, 95% CI 1.93–146.51; p = 0.003). One bleeding complication (0.98%) requiring blood transfusion was recorded. Conclusion US-guided tissue sampling demonstrated a high diagnostic yield and a low complication rate among pediatric patients at TASH. These findings support the use of US-guided tissue sampling in the pediatric population at TASH and suggest its potential for wider application in similar settings in Ethiopia.
No takes yet. Share an insight, caveat, or question.
Ketema et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: